MECHELEN, Belgium, Dec. 16, 2013 (GLOBE NEWSWIRE) -- Galapagos NV (Euronext: GLPG) announced today that it nominated a pre-clinical candidate potentiator for clinical development in its cystic fibrosis (CF) program.
Help employers find you! Check out all the jobs and post your resume.
